Activity of SHIP, Which Prevents Expression of Interleukin 1β, Is Reduced in Patients With Crohn's Disease.
Ngoh EN, Weisser SB, Lo Y, Kozicky LK, Jen R, Brugger HK, Menzies SC, McLarren KW, Nackiewicz D, van Rooijen N, Jacobson K, Ehses JA, Turvey SE, Sly LM.
Ngoh EN, et al. Among authors: van rooijen n.
Gastroenterology. 2016 Feb;150(2):465-76. doi: 10.1053/j.gastro.2015.09.049. Epub 2015 Oct 19.
Gastroenterology. 2016.
PMID: 26481854